Company details
About
Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF). Algernon’s key compounds were identified using a drug repurposing strategy.
Number of employees
1 - 10
Main industry
Health Care
Industry tags
Founded in
2015
Headquarters
Canada
Country
United States
Sign up to uncover company details
5 free credit every month
Employee contacts
Name
Job Title
Phone
Reach Decision Makers
at Algernon Pharmaceuticals
